Vir Biotechnology (VIR) Net Margin (2018 - 2025)
Historic Net Margin for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to 67975.42%.
- Vir Biotechnology's Net Margin fell 589957100.0% to 67975.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 2963.54%, marking a year-over-year decrease of 22851400.0%. This contributed to the annual value of 703.4% for FY2024, which is 102900.0% up from last year.
- Vir Biotechnology's Net Margin amounted to 67975.42% in Q3 2025, which was down 589957100.0% from 9139.87% recorded in Q2 2025.
- In the past 5 years, Vir Biotechnology's Net Margin ranged from a high of 106.57% in Q3 2021 and a low of 67975.42% during Q3 2025
- For the 5-year period, Vir Biotechnology's Net Margin averaged around 6127.76%, with its median value being 690.85% (2023).
- In the last 5 years, Vir Biotechnology's Net Margin soared by 85902100bps in 2022 and then crashed by -589957100bps in 2025.
- Quarter analysis of 5 years shows Vir Biotechnology's Net Margin stood at 64.63% in 2021, then crashed by -418bps to 205.63% in 2022, then plummeted by -236bps to 690.85% in 2023, then decreased by -22bps to 845.23% in 2024, then plummeted by -7942bps to 67975.42% in 2025.
- Its Net Margin stands at 67975.42% for Q3 2025, versus 9139.87% for Q2 2025 and 3989.61% for Q1 2025.